JPMORGAN CHASE & CO - NORTHWEST BIOTHERAPEUTICS IN ownership

NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 86 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q2 2015. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of NORTHWEST BIOTHERAPEUTICS IN
ValueSharesWeighting
Q3 2016$1,0000.0%1,726
-0.5%
0.00%
Q2 2016$1,000
-80.0%
1,734
+3.0%
0.00%
Q4 2015$5,000
-98.2%
1,683
-95.6%
0.00%
Q1 2015$285,000
+0.4%
38,630
-1.5%
0.00%
Q1 2014$284,00039,1990.00%
Other shareholders
NORTHWEST BIOTHERAPEUTICS IN shareholders Q2 2015
NameSharesValueWeighting ↓
Moloney Securities Asset Management, LLC 352,660$320,8150.06%
Opus Capital Group, LLC 60,150$550.01%
AlphaMark Advisors, LLC 14,007$130.01%
ADVISORS MANAGEMENT GROUP INC /ADV 10,270$90.00%
LEE DANNER & BASS INC 20,000$180.00%
Williams Jones Wealth Management, LLC. 44,000$40,0270.00%
MAI Capital Management 20,000$18,1940.00%
Bartlett & Co. LLC 4,292$40.00%
Coston, McIsaac & Partners 1,000$00.00%
View complete list of NORTHWEST BIOTHERAPEUTICS IN shareholders